NCT06823063View on ClinicalTrials.gov

Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

December 31, 2026

Conditions

CTD-ILD

Interventions

BIOLOGICAL

MSC

a single injection dose i.v.

Trial Locations (1)

Unknown

Shanghai Sixth People's Hospital, Shanghai

All Listed Sponsors

lead

Shanghai IxCell Biotechnology Co., LTD

OTHER